Medicine and Dentistry
Atopic Dermatitis
100%
Topical Drug Administration
100%
Thrombocyte Activating Factor Antagonist
100%
Platelet-Activating Factor
40%
Placebo
40%
Combination Therapy
20%
In Vitro
20%
Pathophysiology
20%
Mediator
20%
Pruritus
20%
Erythema
20%
Visual Analog Scale
20%
Antipruritic
20%
Keyphrases
Atopic Dermatitis
100%
Topical Application
100%
Platelet-activating Factor
100%
Placebo
28%
Pathophysiology
14%
Therapeutic Efficacy
14%
Patient Study
14%
Erythema
14%
Pro-inflammatory Activity
14%
Visual Analog Scale
14%
Pruritus
14%
Twice Daily
14%
Exudation
14%
Overall Assessment
14%
Induration
14%
Lipid Mediators
14%
Wilcoxon
14%
Antipruritic
14%
Nursing and Health Professions
Atopic Dermatitis
100%
Thrombocyte Activating Factor Antagonist
100%
Topical Drug Administration
100%
Thrombocyte Activating Factor
40%
Placebo
40%
Antipruritic Agent
20%
Visual Analog Scale
20%
Combination Therapy
20%
Pruritus
20%
Pathophysiology
20%
Erythema
20%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombocyte Activating Factor Antagonist
100%
Atopic Dermatitis
100%
Placebo
40%
Thrombocyte Activating Factor
40%
Pruritus
20%
Antipruritic Agent
20%
Pathophysiology
20%
Combination Therapy
20%
Erythema
20%